Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042811786> ?p ?o ?g. }
- W2042811786 endingPage "584" @default.
- W2042811786 startingPage "574" @default.
- W2042811786 abstract "Treatment of degenerating basal forebrain cholinergic neurons with nerve growth factor (NGF) in Alzheimer's disease has long been contemplated, but an effective and safe delivery method has been lacking. Towards achieving this goal, we are currently developing CERE-110, an adeno-associated virus-based gene delivery vector that encodes for human NGF, for stereotactic surgical delivery to the human nucleus basalis of Meynert. Results indicate that NGF transgene delivery to the targeted brain region via CERE-110 is reliable and accurate, that NGF transgene distribution can be controlled by altering CERE-110 dose, and that it is possible to achieve restricted NGF expression limited to but covering the target brain region. Results from animals examined at longer time periods of 3, 6, 9 and 12 months after CERE-110 delivery indicate that NGF transgene expression is stable and sustained at all time points, with no loss or build-up of protein over the long-term. In addition, results from a series of experiments indicate that CERE-110 is neuroprotective and neurorestorative to basal forebrain cholinergic neurons in the rat fimbria-fornix lesion and aged rat models, and has bioactive effects on young rat basal forebrain cholinergic neurons. These findings, as well as those from several additional non-clinical experiments conducted in both rats and monkeys, led to the initiation of a Phase I clinical study to evaluate the safety and efficacy of CERE-110 in Alzheimer's disease subjects, which is currently ongoing." @default.
- W2042811786 created "2016-06-24" @default.
- W2042811786 creator A5011313043 @default.
- W2042811786 creator A5013991433 @default.
- W2042811786 creator A5033091259 @default.
- W2042811786 creator A5055508729 @default.
- W2042811786 creator A5063136195 @default.
- W2042811786 creator A5068520602 @default.
- W2042811786 creator A5085033596 @default.
- W2042811786 date "2008-06-01" @default.
- W2042811786 modified "2023-10-16" @default.
- W2042811786 title "Therapeutic potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons" @default.
- W2042811786 cites W1500220781 @default.
- W2042811786 cites W1539302044 @default.
- W2042811786 cites W1609471181 @default.
- W2042811786 cites W1638939027 @default.
- W2042811786 cites W1639832183 @default.
- W2042811786 cites W1647778121 @default.
- W2042811786 cites W1763312801 @default.
- W2042811786 cites W1813932451 @default.
- W2042811786 cites W1820424262 @default.
- W2042811786 cites W1842160119 @default.
- W2042811786 cites W1927132367 @default.
- W2042811786 cites W1963143659 @default.
- W2042811786 cites W1965708428 @default.
- W2042811786 cites W1966069671 @default.
- W2042811786 cites W1972514500 @default.
- W2042811786 cites W1981023104 @default.
- W2042811786 cites W1982064952 @default.
- W2042811786 cites W1982312003 @default.
- W2042811786 cites W1986609940 @default.
- W2042811786 cites W1986900475 @default.
- W2042811786 cites W1997053715 @default.
- W2042811786 cites W1999385494 @default.
- W2042811786 cites W1999667056 @default.
- W2042811786 cites W2004713321 @default.
- W2042811786 cites W2008350281 @default.
- W2042811786 cites W2012277777 @default.
- W2042811786 cites W2016544836 @default.
- W2042811786 cites W2017444975 @default.
- W2042811786 cites W2018443310 @default.
- W2042811786 cites W2021280501 @default.
- W2042811786 cites W2024228411 @default.
- W2042811786 cites W2026702698 @default.
- W2042811786 cites W2026745182 @default.
- W2042811786 cites W2031606825 @default.
- W2042811786 cites W2031928363 @default.
- W2042811786 cites W2036996542 @default.
- W2042811786 cites W2037194302 @default.
- W2042811786 cites W2037641328 @default.
- W2042811786 cites W2040402315 @default.
- W2042811786 cites W2040700904 @default.
- W2042811786 cites W2042812490 @default.
- W2042811786 cites W2043650944 @default.
- W2042811786 cites W2043670234 @default.
- W2042811786 cites W2045776001 @default.
- W2042811786 cites W2047945439 @default.
- W2042811786 cites W2048162805 @default.
- W2042811786 cites W2049102811 @default.
- W2042811786 cites W2054392351 @default.
- W2042811786 cites W2056439017 @default.
- W2042811786 cites W2057946562 @default.
- W2042811786 cites W2062706679 @default.
- W2042811786 cites W2066148497 @default.
- W2042811786 cites W2067286874 @default.
- W2042811786 cites W2068885228 @default.
- W2042811786 cites W2069095254 @default.
- W2042811786 cites W2070566742 @default.
- W2042811786 cites W2073374252 @default.
- W2042811786 cites W2075181528 @default.
- W2042811786 cites W2078117109 @default.
- W2042811786 cites W2082414342 @default.
- W2042811786 cites W2082769137 @default.
- W2042811786 cites W2093374391 @default.
- W2042811786 cites W2093545276 @default.
- W2042811786 cites W2096410114 @default.
- W2042811786 cites W2107013935 @default.
- W2042811786 cites W2107761152 @default.
- W2042811786 cites W2110190423 @default.
- W2042811786 cites W2112089287 @default.
- W2042811786 cites W2132590272 @default.
- W2042811786 cites W2146113273 @default.
- W2042811786 cites W2148017536 @default.
- W2042811786 cites W2161483044 @default.
- W2042811786 cites W2330956224 @default.
- W2042811786 cites W2410777962 @default.
- W2042811786 cites W244508287 @default.
- W2042811786 cites W4233449355 @default.
- W2042811786 doi "https://doi.org/10.1016/j.expneurol.2008.03.004" @default.
- W2042811786 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2709503" @default.
- W2042811786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18439998" @default.
- W2042811786 hasPublicationYear "2008" @default.
- W2042811786 type Work @default.
- W2042811786 sameAs 2042811786 @default.
- W2042811786 citedByCount "80" @default.
- W2042811786 countsByYear W20428117862012 @default.
- W2042811786 countsByYear W20428117862013 @default.
- W2042811786 countsByYear W20428117862014 @default.